Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 193

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Cyclooxygenase-2 Expression in Murine and Human Nonmelanoma Skin Cancers: Implications for Therapeutic Approaches¶

An, Kathy P., Athar, Mohammad, Tang, Xiuwei, Katiyar, Santosh K., Russo, Justin, Beech, J., Aszterbaum, Michelle, Kopelovich, Levy, Epstein, Ervin H., Mukhtar, Hasan, Bickers, David R.·2007·Photochemistry and Photobiology
DOI 10.1562/0031-8655(2002)0760073ceimah2.0.co2
Open this paper in CoChat — free account

Abstract

Inflammatory stimuli result in the production of cutaneous eicosanoids, which are known to contribute to the process of tumor promotion. Cyclooxygenase (COX), the rate-limiting enzyme for the production of prostaglandins (PG) from arachidonic acid, exists in at least two isoforms, COX-1 and COX-2. COX-1 is constitutively expressed in most tissues and plays various physiological roles, whereas increased COX-2 expression is known to occur in several types of epithelial neoplasms. Enhanced PG synthesis is a potential contributing factor in UVB-induced nonmelanoma skin cancers (NMSC). Increased COX-2 staining occurs in murine skin neoplasms after chronic exposure to carcinogenic doses of UVB. In this study, immunohistochemical and Western blot analyses were employed to assess longitudinally COX-2 expression in a standard mouse UVB complete carcinogenesis protocol and in human basal cell carcinomas (BCC) and squamous cell carcinomas (SCC). During UVB irradiation of mice, COX-2 expression consistently increased in the hyperplastic skin, the benign papillomas and the SCC. COX-2 expression was also increased in human actinic keratoses, SCC and BCC as well as in murine SCC and BCC. The pattern of COX-2 expression was quite variable, occurring in a patchy distribution in some lesions with staining confined mainly to suprabasal cell layers. In general, COX-2 expression progressively became more extensive in benign papillomas and well-differentiated murine SCC. The staining was predominantly cytoplasmic and perinuclear in some focal areas in tissue stroma around both murine and human tumors. Western blot analysis confirmed negative COX-2 expression in normal skin, whereas acute UVB exposure resulted in increased enzyme expression, which continued to increase in developing papillomas and SCC. Because of the evidence indicating a pathogenic role for eicosanoids in murine and human skin neoplasms, we performed studies to assess the anti-inflammatory and anticarcinogenic effects of green tea extracts, which are potent antioxidants. Acute exposure of the human skin to UVB (minimum erythema dose x 4) caused a transient enhancement of the COX-2 expression, which reverted to baseline within hours; however, in murine skin the expression persisted for several days. Pretreatment with the topically applied green tea extract (1 mg/cm2) largely abrogated the acute COX-2 response to UVB in mice or humans. In summary, enhanced COX-2 expression serves as a marker of epidermal UVB exposure for murine and human NMSC. These results suggest that COX-2 inhibitors could have potent anticarcinogenic effects in UVB-induced skin cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1562/0031-8655(2002)0760073ceimah2.0.co2

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 49

  1. Langenbach, 1999, Cyclooxygenase-deficient mice. A summary of their characteristics and susceptibilities to inflammation and carcinogenesis, Ann. N Y Acad. Sci, 889, 52, 10.1111/j.1749-6632.1999.tb08723.x · DOI · Paper page
  2. Fosslien, 2000, Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia, Crit. Rev. Clin. Lab. Sci, 37, 431, 10.1080/10408360091174286 · DOI · Paper page
  3. Vane, 1994, Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation, Proc. Natl. Acad. Sci. U S A, 91, 2046, 10.1073/pnas.91.6.2046 · DOI · Paper page
  4. Chapple, 2000, Localization of cyclooxygenase-2 in human sporadic colorectal adenomas, Am. J. Pathol, 156, 545, 10.1016/S0002-9440(10)64759-1 · DOI · Paper page
  5. Marks, 2000, A causal relationship between unscheduled eicosanoid signaling and tumor development: cancer chemoprevention by inhibitors of arachidonic acid metabolism, Toxicology, 153, 11, 10.1016/S0300-483X(00)00301-2 · DOI
  6. Marks, 2000, Cancer chemoprevention through interruption of multistage carcinogenesis. The lessons learnt by comparing mouse skin carcinogenesis and human large bowel cancer, Eur. J. Cancer, 36, 314, 10.1016/S0959-8049(99)00318-4 · DOI
  7. Marks, 1999, Metabolic targets of cancer chemoprevention: interruption of tumor development by inhibitors of arachidonic acid metabolism, Recent Results Cancer Res, 151, 45, 10.1007/978-3-642-59945-3_4 · DOI
  8. Buckman, 1998, COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer, Carcinogenesis, 19, 723, 10.1093/carcin/19.5.723 · DOI · Paper page
  9. Pentland, 1999, Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition, Carcinogenesis, 20, 1939, 10.1093/carcin/20.10.1939 · DOI · Paper page
  10. Leung, 2001, Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer, Br. J. Cancer, 84, 335, 10.1054/bjoc.2000.1607 · DOI
  11. Ryu, 2000, High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion, Gynecol. Oncol, 76, 320, 10.1006/gyno.1999.5690 · DOI
  12. Shirahama, 2001, Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder, Cancer, 92, 188, 10.1002/1097-0142(20010701)92:1<188::AID-CNCR1308>3.0.CO;2-W · doi:10.1002/1097-0142(20010701)92:1<188::aid-cncr1308>3.0.co;2-w
  13. Chinery, 1999, Prostaglandin J2 and 15-deoxy-delta12,14-prostaglandin J2 induce proliferation of cyclooxygenase-depleted colorectal cancer cells, Cancer Res, 59, 2739
  14. Athar, 2001, Ultraviolet B (UVB)-induced cox-2 expression in murine skin: an immunohistochemical study, Biochem. Biophys. Res. Commun, 280, 1042, 10.1006/bbrc.2000.4201 · DOI
  15. Aszterbaum, 1999, Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice, Nat. Med, 5, 1285, 10.1038/15242 · DOI · Paper page
  16. Talley, 1999, Selective inhibitors of cyclooxygenase-2 (COX-2), Prog. Med. Chem, 36, 201, 10.1016/S0079-6468(08)70048-1 · DOI · Paper page
  17. Oshima, 1996, Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2), Cell, 87, 803, 10.1016/S0092-8674(00)81988-1 · DOI · Paper page
  18. Liu, 2001, Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice, J. Biol. Chem, 276, 18563, 10.1074/jbc.M010787200 · DOI · Paper page
  19. Fosslien, 2000, Molecular pathology of cyclooxygenase-2 in neoplasia, Ann. Clin. Lab. Sci, 30, 3
  20. Williams, 1999, The role of COX-2 in intestinal cancer, Ann. N Y Acad. Sci, 889, 72, 10.1111/j.1749-6632.1999.tb08725.x · DOI
  21. Bauer, 2000, High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumors, Carcinogenesis, 21, 543, 10.1093/carcin/21.4.543 · doi:10.1093/carcin/21.4.543
  22. Karim, 2000, Cox-2 expression in retinoblastoma, Am. J. Ophthalmol, 129, 398, 10.1016/S0002-9394(99)00355-4 · doi:10.1016/s0002-9394(99)00355-4
  23. Shirvani, 2000, Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: ex vivo induction by bile salts and acid exposure, Gastroenterology, 118, 487, 10.1016/S0016-5085(00)70254-X · DOI · Paper page
  24. Lim, 2000, Increased expression of cyclooxygenase-2 protein in human gastric carcinoma, Clin. Cancer Res, 6, 519
  25. Kitayama, 1999, Increased expression of cyclooxygenase-2 protein in rat urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine, Carcinogenesis, 20, 2305, 10.1093/carcin/20.12.2305 · DOI
  26. Gupta, 2000, Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma, Prostate, 42, 73, 10.1002/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G · DOI · Paper page
  27. Hwang, 1998, Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer, J. Natl. Cancer Inst, 90, 455, 10.1093/jnci/90.6.455 · DOI · Paper page
  28. Denkert, 2001, Expression of cyclooxygenase 2 in human malignant melanoma, Cancer Res, 61, 303
  29. Higashi, 2000, Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells: evidence for growth suppression by inhibiting COX-2 expression, Int. J. Cancer, 86, 667, 10.1002/(SICI)1097-0215(20000601)86:5<667::AID-IJC10>3.0.CO;2-Y · doi:10.1002/(sici)1097-0215(20000601)86:5<667::aid-ijc10>3.0.co;2-y
  30. Furstenberger, 1989, Eicosanoids and multistage carcinogenesis in NMRI mouse skin: role of prostaglandins E and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion), Carcinogenesis, 10, 91, 10.1093/carcin/10.1.91 · DOI
  31. Grewe, 1993, Analysis of the mechanism of ultraviolet (UV) B radiation-induced prostaglandin E2 synthesis by human epidermoid carcinoma cells, J. Investig. Dermatol, 101, 528, 10.1111/1523-1747.ep12365904 · DOI
  32. Woodhead, 1999, Environmental factors in nonmelanoma and melanoma skin cancer, J. Epidemiol, 9, 102, 10.2188/jea.9.6sup_102 · DOI
  33. Wikonkal, 1999, Ultraviolet radiation induced signature mutations in photocarcinogenesis, J. Investig. Dermatol. Symp. Proc, 4, 6, 10.1038/sj.jidsp.5640173 · DOI · Paper page
  34. Ouhtit, 1998, UV-radiation-specific p53 mutation frequency in normal skin as a predictor of risk of basal cell carcinoma, J. Natl. Cancer Inst, 90, 523, 10.1093/jnci/90.7.523 · DOI
  35. Subbaramaiah, 1999, Inhibition of cyclooxygenase-2 gene expression by p53, J. Biol. Chem, 274, 10911, 10.1074/jbc.274.16.10911 · DOI · Paper page
  36. Leong, 1996, Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation, Exp. Cell Res, 224, 79, 10.1006/excr.1996.0113 · DOI
  37. Shattuck-Brandt, 2000, Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10(−/−) mice, Gastroenterology, 118, 337, 10.1016/S0016-5085(00)70216-2 · DOI · Paper page
  38. Tomozawa, 2000, Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer, Br. J. Cancer, 83, 324, 10.1054/bjoc.2000.1270 · DOI · Paper page
  39. Kagoura, 2001, Immunohistochemical expression of cyclooxygenase-2 in skin cancers, J. Cutan. Pathol, 28, 298, 10.1034/j.1600-0560.2001.028006298.x · DOI
  40. Muller-Decker, 1998, Localization of prostaglandin-H synthase-1 and −2 in mouse skin: implications for cutaneous function, Exp. Cell Res, 242, 84, 10.1006/excr.1998.4068 · DOI
  41. Fischer, 1999, Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis, Mol. Carcinog, 25, 231, 10.1002/(SICI)1098-2744(199908)25:4<231::AID-MC1>3.0.CO;2-F · DOI · Paper page
  42. Wang, 1999, Overexpression of protein kinase C-alpha in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2 and TNF-alpha expression but not tumor promotion, J. Cell Sci, 112, 3497, 10.1242/jcs.112.20.3497 · DOI
  43. Wang, 2001, Protein kinase C-alpha coordinately regulates cytosolic phospholipase A(2) activity and the expression of cyclooxygenase-2 through different mechanisms in mouse keratinocytes, Mol. Pharmacol, 59, 860, 10.1124/mol.59.4.860 · DOI
  44. She, 2000, ERKs and p38 kinase phosphorylate p53 protein at serine 15 in response to UV radiation, J. Biol. Chem, 275, 20444, 10.1074/jbc.M001020200 · DOI · Paper page
  45. Zhao, 1999, Photoprotective effect of black tea extracts against UVB-induced phototoxicity in skin, Photochem. Photobiol, 70, 637, 10.1111/j.1751-1097.1999.tb08263.x · DOI
  46. Pang, 1997, Effect of interleukin-1 beta, tumour necrosis factor-alpha and interferon-gamma on the induction of cyclo-oxygenase-2 in cultured human airway smooth muscle cells, Br. J. Pharmacol, 121, 579, 10.1038/sj.bjp.0701152 · DOI · Paper page
  47. Lin, 2001, Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway, J. Biol. Chem, 276, 48997, 10.1074/jbc.M107829200 · DOI · Paper page
  48. Poligone, 2001, Positive and negative regulation of NF-kappaB by COX-2: roles of different prostaglandins, J. Biol. Chem, 276, 38658, 10.1074/jbc.M106599200 · DOI · Paper page
  49. Gately, 2000, The contributions of cyclooxygenase-2 to tumor angiogenesis, Cancer Metastasis Rev, 19, 19, 10.1023/A:1026575610124 · DOI · Paper page

Cited by

See all 193

Metadata

Authors
An, K. P., Athar, M., Tang, X., Katiyar, S. K., Russo, J., Beech, J., Aszterbaum, M., Kopelovich, L., Epstein, E. H., Mukhtar, H., & Bickers, D. R.
Venue
Photochemistry and Photobiology
Publisher
American Society for Photobiology
Published
2007-05-01
Volume
76
Issue
1
Pages
73-80
ISSN
0031-8655 (ISSN-L)
DOI
10.1562/0031-8655(2002)0760073ceimah2.0.co2
OpenAlex
W2066265024
Cited by
193
References
2
FWCI
5.97
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cyclooxygenase-2 Expression in Murine and Human Nonmelanoma Skin Cancers: Implications for Therapeutic Approaches¶. https://app.cochat.ai/papers/10.1562/0031-8655(2002)0760073ceimah2.0.co2
The paper
An, K. P., Athar, M., Tang, X., Katiyar, S. K., Russo, J., Beech, J., Aszterbaum, M., Kopelovich, L., Epstein, E. H., Mukhtar, H., & Bickers, D. R. (2007). Cyclooxygenase-2 Expression in Murine and Human Nonmelanoma Skin Cancers: Implications for Therapeutic Approaches¶. Photochemistry and Photobiology. https://doi.org/10.1562/0031-8655(2002)0760073ceimah2.0.co2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.